Editas Medicine, Inc. (44)
Browse by Contract Category
Contracts
-
Amendment to RSU Agreement, dated May 24, 2022, between the Registrant and James C. Mullen
(Filed With SEC on August 3, 2022)
-
Employment Offer Letter, dated June 14, 2022, between the Registrant and Baisong Mei
(Filed With SEC on August 3, 2022)
-
License Agreement, dated October 10, 2014, between the Registrant and Duke University
(Filed With SEC on November 9, 2021)
-
License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc
(Filed With SEC on November 9, 2021)
-
Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC
(Filed With SEC on May 14, 2021)
-
Amendment to Employment Offer Letter, dated April 13, 2022, between the Registrant and James C. Mullen
(Filed With SEC on August 3, 2022)
-
Employment Offer Letter, dated April 13, 2022, between the Registrant and Gilmore ONeill
(Filed With SEC on August 3, 2022)
-
Amended Severance Benefits Plan
(Filed With SEC on February 24, 2022)
-
Employment Offer Letter, dated September 22, 2021, between the Registrant and Bruce Eaton
(Filed With SEC on November 9, 2021)
-
License Agreement, dated August 29, 2014, between the Registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital
(Filed With SEC on November 9, 2021)
-
Second Amendment to the Exclusive Patent License Agreement, by and between the Company and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated November...
(Filed With SEC on November 9, 2021)
-
Letter Agreement, dated October 9, 2015, between the Registrant and Duke University
(Filed With SEC on November 9, 2021)
-
License Agreement, dated October 29, 2014, among the Registrant, the President and Fellows of Harvard College, and the Broad Institute, Inc
(Filed With SEC on November 9, 2021)
-
Summary of Non-Employee Director Compensation Program
(Filed With SEC on August 5, 2021)
-
Employment Offer Letter, dated April 19, 2021, between the Registrant and Mark S. Shearman
(Filed With SEC on August 5, 2021)
-
Letter Agreement, dated February 15, 2021, by and between the Registrant and Cynthia Collins
(Filed With SEC on February 26, 2021)
-
Omnibus Amendment, dated as of January 11, 2021, by and between the Registrant and Broad
(Filed With SEC on February 26, 2021)
-
Summary of Director Compensation Program
(Filed With SEC on February 26, 2021)
-
First Amendment to Sponsored Research Agreement, dated January 11, 2021, between the Registrant and Broad
(Filed With SEC on February 26, 2021)
-
Employment Offer Letter, dated September 25, 2020, between the Registrant and Lisa A. Michaels, M.D
(Filed With SEC on February 26, 2021)
-
Employment Offer Letter, dated February 14, 2021, between the Registrant and James C. Mullen
(Filed With SEC on February 26, 2021)
-
Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC
(Filed With SEC on January 21, 2021)
-
Termination Agreement, dated August 5, 2020, by and between the Company and Allergan Sales, LLC
(Filed With SEC on November 6, 2020)
-
Advisory Services Agreement, Dated May 1, 2020, by and between the Company and Judith Abrams
(Filed With SEC on August 7, 2020)
-
Separation Agreement, dated as of April 30, 2020, by and between the Company and Judith Abrams
(Filed With SEC on August 7, 2020)
-
Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter
(Filed With SEC on June 25, 2020)
-
Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen
(Filed With SEC on May 15, 2020)
-
Amended Severance Benefits Plan
(Filed With SEC on February 26, 2020)
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 26, 2020)
-
Employment Offer Letter, dated October 11, 2019, between the Registrant and Judith R. Abrams, M.D
(Filed With SEC on February 26, 2020)
-
Employment Offer Letter, dated December 27, 2019, between the Registrant and Michelle Robertson
(Filed With SEC on February 26, 2020)
-
Form of Inducement Stock Option Agreement for the Registrants executive officers
(Filed With SEC on February 26, 2020)
-
Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers
(Filed With SEC on February 26, 2020)
-
Letter Agreement, dated as of November 18, 2019, by and among, the Registrant, Broad and Harvard
(Filed With SEC on February 26, 2020)
-
Letter Agreement, dated as of December 16, 2019, by and among, the Registrant, Broad and Harvard
(Filed With SEC on February 26, 2020)
-
Second Amended and Restated License and Collaboration Agreement, dated November 11, 2019, between the Registrant and Juno Therapeutics, Inc. (Juno)
(Filed With SEC on February 26, 2020)
-
License and Agreement, dated November 11, 2019, between the Registrant and Juno
(Filed With SEC on February 26, 2020)
-
Letter Agreement, dated September 26, 2019, by and between the Registrant and Vic Myer, Ph.D
(Filed With SEC on November 12, 2019)
-
Offer Letter, dated August 6, 2019, by and between the Registrant and Cynthia Collins
(Filed With SEC on November 12, 2019)
-
Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins
(Filed With SEC on May 8, 2019)
-
Co-Development and Commercialization Agreement, dated February 22, 2019, by and between the Registrant and Allergan Sales, LLC
(Filed With SEC on May 8, 2019)
-
Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley
(Filed With SEC on May 8, 2019)
-
Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D
(Filed With SEC on March 1, 2019)
-
Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan
(Filed With SEC on January 22, 2019)